Pfizer and Wyeth to Divest Some Animal Health Assets to Boehringer Ingelheim

Pfizer and Wyeth say they will divest certain animal health assets to Boehringer Ingelheim, in connection with the regulatory approval process associated with Pfizer’s pending acquisition of Wyeth. Boehringer Ingelheim will acquire products, research and manufacturing facilities, located at Fort Dodge, IA, as well as related assets and intellectual property, primarily from Wyeth’s Fort Dodge Animal Health portfolio in Canada and the U.S., under the terms of the deal. Boehringer Ingelheim also plans to acquire certain animal health assets in other...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers